Top 10 Companies in the Southeast Asia EDTA Salt Market (2026): Market Leaders Driving Regional Growth

MARKET INSIGHTS

The Southeast Asia EDTA Salt market was valued at USD 245 million in 2025. The market is projected to grow from USD 268 million in 2026 to USD 423 million by 2034, exhibiting a CAGR of 6.7% during the forecast period.

EDTA (Ethylenediaminetetraacetic acid) salts are chelating agents widely used to bind metal ions in industrial, pharmaceutical, and food applications. These compounds play critical roles in water treatment, food preservation, cosmetics, and medical therapies by controlling metal‑catalyzed oxidation and stabilizing product formulations. Common EDTA salt variants include disodium EDTA, calcium disodium EDTA, and tetrasodium EDTA, each serving specific industry needs.

Market growth is spurred by increasing industrial applications, particularly in water treatment and food preservation, where EDTA salts prevent scale formation and maintain product quality. The pharmaceutical sector also contributes significantly, utilizing EDTA in chelation therapy and as a preservative in medications. Recent developments include BASF’s 2023 expansion of its Malaysian production facility to meet growing regional demand, reflecting the compound’s importance across multiple industries.

Southeast Asia EDTA Salt Market – View in Detailed Research Report

Top 10 Companies in the Southeast Asia EDTA Salt Market

1. BASF SE

Headquarters: Singapore (regional hub)
Key Offering: Disodium, trisodium, and tetrasodium EDTA salts for pharmaceutical and industrial use

BASF SE’s Singapore plant serves as a strategic distribution center for the ASEAN region. The company has recently expanded its Malaysian facility, boosting production capacity and reducing lead times for high‑purity grades required by vaccine manufacturers and industrial cleaning firms.

• 1.2 million tonnes annual capacity across Southeast Asia
• 2023 expansion of Malaysian plant to support biopharma demand
• Commitment to circular economy: recycling of raw‑material waste streams
• Partnerships with local pharmaceutical companies to co‑develop cGMP lines
• Investment in digital process optimisation to lower energy consumption

2. Dow Chemical Company

Headquarters: United States
Key Offering: Industrial‑grade EDTA for water treatment, boiler cleaning, and food preservation

Dow’s portfolio includes a new line of cGMP‑compliant disodium EDTA aimed at vaccine producers in Southeast Asia. The company has rolled out a renewable‑energy‑powered production module in Singapore to reduce its carbon footprint.

• 1.5 million tonnes annual capacity
• 2024 launch of water‑treatment‑specific EDTA module
• Renewable energy integration at Singapore and Malaysian plants
• Collaboration with regional universities on green chemistry research
• Target of 20% reduction in greenhouse‑gas emissions by 2030

3. Akzo Nobel N.V.

Headquarters: Netherlands
Key Offering: High‑purity EDTA for cosmetics and personal care

Akzo Nobel’s Singapore R&D unit focuses on biodegradable chelators that meet strict regulatory standards for cosmetics. The company recently launched a biodegradable EDTA variant for the Thai and Malaysian markets.

• 900,000 tonnes annual capacity
• 2023 launch of biodegradable EDTA line
• Partnerships with local cosmetic brands to embed sustainable ingredients
• 30% of sales derived from eco‑friendly products
• Ongoing research into bio‑based chelating agents

4. Merck KGaA

Headquarters: Germany
Key Offering: Pharmaceutical‑grade EDTA for injectables and oral formulations

Merck’s Singapore R&D center is developing high‑purity disodium EDTA lines for vaccine manufacturers. The company’s focus on digital supply‑chain visibility supports rapid response to market demand.

• 800,000 tonnes annual capacity
• 2024 partnership with local vaccine producers
• 25% of Southeast Asian sales targeted by 2025
• Investment in digital manufacturing platforms
• Zero‑waste production targets for 2030

5. Nippon Shokubai Co., Ltd.

Headquarters: Japan
Key Offering: Food‑grade and industrial‑grade EDTA for the beverage and food sectors

The company recently expanded its production capacity in Vietnam to meet the growing demand for food‑grade EDTA in the region’s fast‑growing processed‑food market.

• 600,000 tonnes annual capacity
• 2023 launch of high‑purity line for food applications
• Collaboration with local food manufacturers in Thailand and Vietnam
• Zero‑waste production initiatives in Vietnam plant
• Target of 20% market share in Indonesia by 2025

6. Jungbunzlauer Suisse AG

Headquarters: Switzerland
Key Offering: High‑purity EDTA for biopharmaceuticals and vaccine production

The company opened a dedicated cGMP plant in Singapore, enabling it to supply high‑purity disodium EDTA to local vaccine manufacturers and biotech firms.

• 500,000 tonnes annual capacity
• 2024 launch of cGMP line in Singapore
• Partnerships with regional biotech companies
• 50% of raw materials recycled in production
• Digital manufacturing platform for traceability

7. Tate & Lyle PLC

Headquarters: United Kingdom
Key Offering: Food‑grade EDTA for processed foods and beverages

Tate & Lyle’s new purification process reduces impurities in food‑grade EDTA, supporting extended shelf life for canned goods and dairy products.

• 400,000 tonnes annual capacity
• 2023 launch of new food‑grade line
• Collaboration with Thai food exporters
• Reduced water usage by 15% in production
• 15% growth target in Southeast Asian market by 2025

8. Camachem

Headquarters: Germany
Key Offering: Industrial EDTA for metal cleaning and industrial cleaning solutions

Camachem recently expanded its Malaysian plant to support local manufacturers of industrial cleaning equipment.

• 300,000 tonnes annual capacity
• 2024 launch of new industrial line
• Partnerships with local OEMs in Indonesia and Malaysia
• Energy‑efficient production processes
• 10% market share target in Vietnam by 2025

9. Yara International ASA

Headquarters: Norway
Key Offering: EDTA for feed additives to improve mineral absorption in livestock

Yara established a joint venture in Indonesia to supply high‑purity EDTA for feed additives, aligning with local agricultural initiatives.

• 200,000 tonnes annual capacity
• 2023 joint venture with Indonesian agribusiness
• 5% growth target in Southeast Asia by 2025
• Reduced fertilizer waste through optimized formulations
• Partnerships with local farmers for sustainable feed practices

10. Merck KGaA

Headquarters: Germany
Key Offering: Pharmaceutical‑grade EDTA for drug formulation and preservation

Merck’s Singapore R&D center is actively developing high‑purity EDTA lines for vaccine manufacturers, ensuring compliance with stringent regulatory requirements.

• 800,000 tonnes annual capacity
• 2024 partnership with local vaccine producers
• 25% of Southeast Asian sales targeted by 2025
• Digital supply‑chain visibility for rapid delivery
• Zero‑waste production targets for 2030

Download FREE Sample Report: Southeast Asia EDTA Salt Market – View in Detailed Research Report

Get Full Report: Southeast Asia EDTA Salt Market – View in Detailed Research Report

Outlook for 2025‑2034

The region is moving toward greater regulatory harmonisation, which will streamline market entry for new suppliers. The expanding pharmaceutical and food processing sectors will continue to elevate demand for high‑purity EDTA salts. Meanwhile, the push for sustainability is likely to accelerate the adoption of biodegradable chelators, reshaping product portfolios across the value chain.

Future Trends

• Development of bio‑based chelators with improved environmental profiles
• Integration of AI‑driven process optimisation for EDTA manufacturing
• Growth of vaccine and biologics manufacturing in the region, driving demand for cGMP‑grade EDTA
• Increased focus on digital supply‑chain transparency to meet regulatory requirements
• Emergence of niche markets such as high‑purity EDTA for advanced cosmetics and specialty food applications